Search Results - "Kasthuri, Raj S."

Refine Results
  1. 1

    Cancer Therapy–Associated Thrombosis by Grover, Steven P., Hisada, Yohei M., Kasthuri, Raj S., Reeves, Brandi N., Mackman, Nigel

    “…Patients with cancer have an increased risk of both arterial and venous thrombotic events compared with the general population. Both the site and stage of…”
    Get full text
    Journal Article
  2. 2

    Role of Tissue Factor in Cancer by Kasthuri, Raj S, Taubman, Mark B, Mackman, Nigel

    Published in Journal of clinical oncology (10-10-2009)
    “…Tissue factor (TF) is a transmembrane glycoprotein that localizes the coagulation serine protease factor VII/VIIa (FVII/VIIa) to the cell surface. The primary…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Applicability of the Curaçao Criteria for the Diagnosis of Hereditary Hemorrhagic Telangiectasia in the Pediatric Population by Pahl, Kristy S., Choudhury, Arkopal, Wusik, Katie, Hammill, Adrienne, White, Andrew, Henderson, Katharine, Pollak, Jeffrey, Kasthuri, Raj S.

    Published in The Journal of pediatrics (01-06-2018)
    “…To evaluate the accuracy of the clinical Curaçao criteria in the diagnosis of hereditary hemorrhagic telangiectasia (HHT) in children and adolescents. This was…”
    Get full text
    Journal Article
  5. 5

    Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding by Beckman, Joan D, Li, Quefeng, Hester, Samuel T, Leitner, Ofri, Smith, Karen L, Kasthuri, Raj S

    Published in Orphanet journal of rare diseases (13-07-2020)
    “…Hereditary Hemorrhagic Telangiectasia (HHT) is a rare inherited disorder characterized by development of mucocutaneous telangiectases and visceral organ…”
    Get full text
    Journal Article
  6. 6

    Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer by Kasthuri, Raj S., Hisada, Yohei, Ilich, Anton, Key, Nigel S., Mackman, Nigel

    “…We conducted a longitudinal study in patients with pancreatic and colorectal cancer. We determined the effect of chemotherapy on extracellular vesicle tissue…”
    Get full text
    Journal Article
  7. 7

    RBC barcoding allows for the study of erythrocyte population dynamics and P. falciparum merozoite invasion by Clark, Martha A, Goheen, Morgan M, Spidale, Nicholas A, Kasthuri, Raj S, Fulford, Anthony, Cerami, Carla

    Published in PloS one (01-07-2014)
    “…Plasmodium falciparum invasion of host erythrocytes is essential for the propagation of the blood stage of malaria infection. Additionally, the brief…”
    Get full text
    Journal Article
  8. 8

    Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature by Cockrell, Dillon C., Kasthuri, Raj S., Altun, Ersan, Rose, Tracy L., Milowsky, Matthew I.

    Published in Case reports in oncology (25-11-2020)
    “…Immune thrombocytopenia (ITP) is a rare paraneoplastic syndrome of solid tumor malignancies. In previously described cases of renal cell carcinoma (RCC)…”
    Get full text
    Journal Article
  9. 9

    Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity by Boles, Jeremiah C, Williams, Julie C, Hollingsworth, Rachel M, Wang, Jian-Guo, Glover, Sam L, Owens, A. Phillip, Barcel, David A, Kasthuri, Raj S, Key, Nigel S, Mackman, Nigel

    Published in Thrombosis research (01-02-2012)
    “…Abstract Introduction Cancer associated thrombosis is a well-recognized phenomenon that results in considerable patient morbidity and mortality. Malignancy…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management by Hammill, Adrienne M, Wusik, Katie, Kasthuri, Raj S

    Published in Hematology (10-12-2021)
    “…Hereditary hemorrhagic telangiectasia (HHT), the second most common inherited bleeding disorder, is associated with the development of malformed blood vessels…”
    Get full text
    Journal Article
  12. 12

    Plasma protein profiling: Unique and stable features of individuals by Nelsestuen, Gary L., Zhang, Yan, Martinez, Michael B., Key, Nigel S., Jilma, Bernd, Verneris, Michael, Sinaiko, Alan, Kasthuri, RajS.

    Published in Proteomics (Weinheim) (01-10-2005)
    “…Carefully controlled ZipTip extraction of diluted human plasma or serum was combined with MALDI‐TOF‐MS to produce highly reproducible protein profiles…”
    Get full text
    Journal Article
  13. 13

    Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions by Lee, Robert H., Kasthuri, Raj S., Bergmeier, Wolfgang

    Published in Current opinion in hematology (01-11-2020)
    “…PURPOSE OF REVIEWIn this review, we discuss current clinical guidelines and potential underlying mechanisms regarding platelet transfusion therapy in patients…”
    Get full text
    Journal Article
  14. 14

    Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum by Clark, Martha A., Goheen, Morgan M., Fulford, Anthony, Prentice, Andrew M., Elnagheeb, Marwa A., Patel, Jaymin, Fisher, Nancy, Taylor, Steve M., Kasthuri, Raj S., Cerami, Carla

    Published in Nature communications (25-07-2014)
    “…Iron deficiency and malaria have similar global distributions, and frequently co-exist in pregnant women and young children. Where both conditions are…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI by Kasthuri, Raj S., Glover, Sam L., Jonas, William, McEachron, Troy, Pawlinski, Rafal, Arepally, Gowthami M., Key, Nigel S., Mackman, Nigel

    Published in Blood (31-05-2012)
    “…Heparin-induced thrombocytopenia (HIT) is a potentially devastating form of drug-induced thrombocytopenia that occurs in patients receiving heparin for…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients by Raval, Jay S., Mazepa, Marshall A., Rollins‐Raval, Marian A., Kasthuri, Raj S., Park, Yara A.

    Published in Transfusion (Philadelphia, Pa.) (01-08-2020)
    “…BACKGROUND Despite rapid and intensive treatments with therapeutic plasma exchange (TPE) and immunosuppression, immune thrombotic thrombocytopenic purpura…”
    Get full text
    Journal Article